ABSTRACT
Transcranial magnetic stimulation (TMS) of the brain is a somatic treatment in psychiatry approved by the US Food and Drug Administration (FDA) in October 2008 for the treatment of depression under certain conditions. The potential for further development of TMS is great, and psychiatrists should be familiar with its basic principles.
